Teleflex has received a grant from the US Army to develop an anti-biofilm orthopaedic device for the treatment of soldiers.

Awarded by the army’s Telemedicine and Advanced Technology Research Centre (TATRC), the $2.1m grant will support the research and development of a surface-modified tibial intramedullary nail that combines Semprus sustain and antimicrobial technology.

Teleflex president chairman and chief executive officer Benson Smith said: "Teleflex is pleased to partner with the US Army to develop a solution to an unmet need in orthopaedic injuries affecting our wounded men and women in combat.

"Teleflex is pleased to partner with the US Army to develop a solution to an unmet need in orthopaedic injuries."

"This award will help enable Teleflex to combine its proprietary sustain surface modification and antimicrobial solutions to develop a valuable clinical solution to battleground injuries, and we are hopeful that this collaboration will yield greatly improved clinical outcomes for soldiers."

The grant builds upon an initial $1.1m funding awarded by TATRC to Semprus BioSciences in 2011 for the development of the world’s first orthopaedic devices designed to reduce biofilm formation.

The research is scheduled to be conducted at the company’s facilities in Cambridge, Massachusetts, US, in collaboration with the US Army Institute for Surgical Research (USAISR) at Fort Sam Houston in San Antonio, Texas, US.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

An additional $2.46m could be made available by the US Army, if required.

Orthopaedic injuries, which are a common occurrence in the majority of wounded soldiers, can lead to significant morbidity and a failure to return to duty.

The current standard of care for US military personnel includes initial stabilisation with external fixators, followed by delayed conversion to intramedullary (IM) nails.

In addition, the routine use of debridement techniques, negative pressure wound therapy, prophylactic antibiotics, and bone stabilisation, has significantly improved the management and prevention of infections associated with orthopaedic injuries.

However, orthopaedic infections of up to 30% to 40% still occur in traumatic open fractures, which are caused by a blast injury and are typically treated with fixation devices such as intramedullary nails, plates and screws.

The army is seeking new strategies for preventing infection, including bacterial adherence to metal implants, which is considered to be the first step in orthopaedic infection.

Defence Technology